Wolverine Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Wolverine Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-289,500	Closed	-$32K	–	1873
2018 Q4	$32K	Hold	289,500	–	–	﹤0.01%	1458
2018 Q3	$492K	Hold	289,500	–	–	0.01%	1020
2018 Q2	$503K	Buy	289,500 +22,000	+8%	+$38K	0.01%	939
2018 Q1	$489K	Sell	267,500 -214,400	-44%	-$453K	0.01%	977
2017 Q4	$1.07M	Buy	481,900 +34,400	+8%	+$85.5K	0.01%	702
2017 Q3	$1.3M	Buy	447,500 +373,700	+506%	+$1.27M	0.01%	585
2017 Q2	$328K	Hold	73,800	–	–	﹤0.01%	871
2017 Q1	$343K	Buy	73,800 +62,800	+571%	+$364K	0.01%	770
2016 Q4	$66K	Sell	11,000 -9,200	-46%	-$48.1K	﹤0.01%	983
2016 Q3	$111K	Buy	+20,200	New	+$94.6K	﹤0.01%	971

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Wolverine Asset Management's SGYP Position: Q1 2019 in Review

Wolverine Asset Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 236,406 shares — an estimated $26K sold.

Wolverine Asset Management first reported a position in SGYP in Q3 2013 and held it in 6 quarters. The position peaked at $850K in Q4 2013. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Wolverine Asset Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Wolverine Asset Management sold 236,406 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $26K.
Wolverine Asset Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2013 and held it in 6 quarters.
Wolverine Asset Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $850K in Q4 2013.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Wolverine Asset Management's 13F filing for Q1 2019, filed 15 May 2019.